EUVIMEDEUVIMED entdecken
Crossref

Outcomes of long-term central venous access devices in pulmonary arterial hypertension: A 10-year case series

Juan Gómez-Sandoval iD, Valeria Correa-Martinez iD, Javier Amaya-Nieto, Rafael Conde-Camacho, Carlos F Román-Ortega iD

The Journal of Vascular Access · 2026-11 · 27 (6) · 2544-2552

DOI: 10.1177/11297298261457766 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Vascular Access, online erschienen am 23.06.2026. Verfasst von Juan Gómez-Sandoval und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fundación Cardioinfantil - Instituto de Cardiología, Bogotá, Colombia. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Continuous prostacyclin infusion is the standard of care for pulmonary arterial hypertension, requiring central venous access devices where dwell time is critical but associated with complications.

Methods

Retrospective 10-year case series of 18 adult pulmonary arterial hypertension patients managed through central venous access devices by a specialized multidisciplinary team.

Results

Sixty-nine catheters were analyzed across 18 patients; median catheter survival estimated by the Kaplan-Meier method was 9.3 months (95% confidence interval (8.1–12)). Occlusion was the most frequent complication (1.20 per 1,000 catheter-days) and the leading removal reason across all device types. Catheter-related bloodstream infections occurred in four instances (0.22 per 1,000 catheter-days), with methicillin-susceptible Staphylococcus aureus as the only isolated pathogen. Catheter-related thrombosis was documented in two cases. Three catheters fractured, one of each device type.

Discussion

Evidence on central venous access device outcomes in pulmonary arterial hypertension remains scarce in middle-income countries. The median dwell time observed in this series was shorter than that reported in high-income country cohorts, while catheter-related bloodstream infection and thrombosis rates were numerically lower than those documented in comparable series.

Conclusion

In this descriptive 10-year case series from a middle-income country, long-term central venous access devices for continuous epoprostenol infusion in pulmonary arterial hypertension were associated with a prolonged dwell time and low complication rates under a structured multidisciplinary follow-up model. Larger multicenter studies are needed to confirm generalizability and identify determinants of catheter longevity.

Schlagwörter

Stichwörter der Autor:innen

Central venous catheterscatheter obstructioncatheter-related infectionsepoprostenolhypertensionpulmonaryvascular access devices

Autor:innen und Institutionen

  • Fundación Cardioinfantil - Instituto de Cardiología, Bogotá, Colombia.
  • Fundación Neumológica Colombiana Pulmonary Vascular Disease Program NeumoVasc Rexpira, Bogotá, Colombia.

ORCID-Profile: Juan Gómez-Sandoval, Valeria Correa-Martinez, Carlos F Román-Ortega

Zitieren

APA

Gómez-Sandoval, J., Correa-Martinez, V., Amaya-Nieto, J., Conde-Camacho, R., & Román-Ortega, C. F. (2026). Outcomes of long-term central venous access devices in pulmonary arterial hypertension: A 10-year case series. The Journal of Vascular Access, 27(6), 2544-2552. https://doi.org/10.1177/11297298261457766

Vancouver

Gómez-Sandoval J, Correa-Martinez V, Amaya-Nieto J, Conde-Camacho R, Román-Ortega CF. Outcomes of long-term central venous access devices in pulmonary arterial hypertension: A 10-year case series. The Journal of Vascular Access. 2026;27(6):2544-2552. doi:10.1177/11297298261457766

BibTeX
@article{GmezSandoval2026,
  author = {Gómez-Sandoval, Juan and Correa-Martinez, Valeria and Amaya-Nieto, Javier and Conde-Camacho, Rafael and Román-Ortega, Carlos F},
  title = {Outcomes of long-term central venous access devices in pulmonary arterial hypertension: A 10-year case series},
  journal = {The Journal of Vascular Access},
  year = {2026},
  volume = {27},
  number = {6},
  pages = {2544--2552},
  doi = {10.1177/11297298261457766}
}
Kostenlos starten →